Skip to main content
. 2014 Feb 24;20(5):403–410. doi: 10.1111/cns.12227

Table 1.

Characteristics of the patients (n = 862)

Characteristic Derivation group (n = 575) Validation group (n = 287) P value
Demographic characteristics
Older age (≥65), y ,(n, %) 342 (59.5) 167 (58.2) >0.05
Female gender 215 (37.4) 107 (37.3) >0.05
Obesity (BMI ≥ 25 kg/m2) 229 (40.2) 116 (40.8) >0.05
Risk factors for stroke
Arterial hypertension 373 (64.9) 180 (62.7) >0.05
Diabetes mellitus 151 (26.3) 71 (24.7) >0.05
Atrial fibrillation 55 (9.6) 24 (8.4) >0.05
Currently smoking 241 (41.9) 107 (37.3) >0.05
Alcoholism 176 (30.6) 87 (30.3) >0.05
Metabolism syndrome 210 (37.0) 89 (32.0) >0.05
Laboratory results
TG (median,range) 185 (32.2) 76 (26.5) >0.05
TC 113 (19.7) 57 (19.9) >0.05
HDL 98 (17.0) 58 (20.2) >0.05
LDL 165 (28.7) 88 (30.7) >0.05
Fast glucose 241 (42.5) 110 (39.6) >0.05
eGFR 448 (82.2) 219 (80.8) >0.05
BUN 65 (11.3) 37 (12.9) >0.05
SCr 47 (8.2) 33 (11.5) >0.05
UA 58 (10.1) 37 (12.9) >0.05
Acute stroke characteristics
Acute ischemic stroke 462 (80.3) 218 (76.0) >0.05
NIHSS 12 (9, 16) 12 (9, 17) >0.05
Lower limb NIHSS score ≥ 2 315 (54.9) 165 (58.9) >0.05
Risk factors for deep venous thrombosis
Active cancer 12 (2.1) 7 (2.4) >0.05
Vein puncture 30 (5.2) 11 (3.8) >0.05
DVT prophylaxis strategies
Anticoagulation in ischmeic stroke* 105 (22.7) 48 (22.0) >0.05
Antiplatelet agents in ischmeic stroke 372 (80.5) 177 (80.2) >0.05
Deambulation under the supervision of a physical therapist 267 (46.4) 129 (44.9) >0.05
Frequence of deep venous thrombosis 76 (13.2) 30 (10.5) >0.05

BMI, body mass index; DVT, deep‐vein thrombosis. *Included anticoagulation in cardioembolsim etc.